Cardiac tamponade caused by acute coxsackievirus infection related pericarditis complicated by aortic stenosis in a hemodialysis patient: a case report
- 60 Downloads
Pericardial effusion is observed in the majority of viral pericarditis cases; however, viral pericarditis accompanied by a large effusion resulting in cardiac tamponade is rare.
Here, we report the case of a 75-year-old hemodialysis patient with acute viral pericarditis complicated by aortic stenosis. The patient was referred with a diagnosis of aortic stenosis and pericardial effusion. The pericardial effusion had increased during the preoperative examinations, and the inflammatory reaction had progressed. We decided to abort the surgical intervention and start oral administration of anti-inflammatory agents. We subsequently performed a pericardiocentesis. High antibody titers to coxsackievirus were noted in the pericardial effusion. Since no recurrence of the pericardial effusion was observed, the patient underwent an aortic valve replacement 2 months later. The pericardium completely adhered to the heart. Pathological examination of the pericardium showed fibrous pericarditis without active inflammation.
Here, we successfully treated a hemodialysis case with severe aortic stenosis complicated by cardiac tamponade and worsened by acute viral pericarditis. We waited for the pericarditis to resolve after administering anti-inflammatory agents and performed pericardial drainage before carrying out aortic valve replacement. The perioperative course of our case was unique and suggestive.
KeywordsAcute pericarditis Aortic stenosis Hemodialysis Coxsackievirus Cardiac tamponade
Aortic valve replacement
Effective orifice area
End-stage renal dysfunction
White blood cell
Pericarditis can be a manifestation of infection, connective tissue disorders, malignancy, hypothyroidism, trauma, and end-stage renal dysfunction (ESRD) . Pericarditis in ESRD patients can be categorized into uremic and dialysis-associated types . Uremic pericarditis usually occurs before renal replacement therapy, whereas dialysis-associated pericarditis typically occurs in poorly controlled hemodialysis patients. On the other hand, pericardial effusion is observed in more than half of viral pericarditis cases; however, viral pericarditis accompanied by a large effusion resulting in cardiac tamponade is rare .
Here, we report the case of a 75-year-old hemodialysis patient with acute viral pericarditis complicated by aortic stenosis (AS). In this case, it was difficult to distinguish whether the pericarditis etiology was viral, hemodialysis-associated, or due to other causes. The perioperative course of our case was unique and suggestive.
The elective operation was performed. The pericardium was thickened and showed almost complete adherence to the heart. Following meticulous dissection of the adhesions, isolation of the right pulmonary veins was performed with a radiofrequency ablator (Isolator Synergy Clamp OSL2; AtriCure Inc., West Chester, OH, USA) before the initiation of cardiopulmonary bypass (CPB). After the establishment of CPB, dissection of the adhesion around the left pulmonary veins was performed and the left pulmonary veins were similarly isolated. Myocardial protection was achieved using intermittent antegrade and retrograde cold blood cardioplegia. The aortic valve was exposed via an aortotomy. A visual inspection revealed calcified cusps and annulus. The cusps were resected, and the calcifications on the annulus were gently removed using an ultrasonic aspirator (Sonopet UST-2001; Stryker Japan Inc., Tokyo, Japan). A 23-mm stentless bioprosthesis (Solo Smart; Sorin Group, Milan, Italy) was implanted with three continuously running 4–0 monofilament polypropylene sutures. Aortic cross-clamp time and CPB time were 72 and 127 min, respectively. The patient tolerated the procedure well and had an uncomplicated postoperative course. Postoperative TTE showed no aortic regurgitation. The effective orifice area (EOA) and indexed EOA of the bioprosthesis were calculated as 1.73 cm2 and 1.08 cm2/m2, respectively, and mean pressure gradient across the prosthetic valve was 10 mmHg. Anti-platelet therapy (aspirin 100 mg/day) was initiated on the first postoperative day. The patients had no adverse events during 1 year and 9 months of follow-up, and his sinus rhythm has been maintained.
Viral pericarditis accounts for the majority of acute pericarditis cases and is rarely life-threatening. Pericarditis can result from the direct viral infection of the pericardium, most commonly adenovirus or coxsackievirus [3, 4]. Bacterial pericarditis is also recognized as an infectious pericarditis that usually results from direct or hematogenous spread from other sites of infection, such as pneumonia, osteomyelitis, or meningitis. Tuberculous pericarditis is a special type of bacterial pericarditis that is strongly associated with the development of constrictive pericarditis. Pericarditis can also be a manifestation of connective tissue disorders, malignancy, hypothyroidism, trauma, and ESRD .
Pericarditis in ESRD patients can be categorized into uremic and dialysis-associated types . Uremic pericarditis is characteristically described as the onset of pericarditis before renal replacement therapy or within 8 weeks of its initiation, whereas dialysis-associated pericarditis typically occurs after 8 weeks of dialysis. The reported incidence of dialysis-associated pericarditis is 2–21%. Uremic pericarditis usually resolves with dialysis and rarely causes complications. Dialysis-associated pericarditis is rare in well-controlled hemodialysis patients. Inadequate dialysis and/or fluid overload may contribute to this pathology. Banerjee and Davenport suggested that when ESRD patients on adequate dialysis develop pericarditis, early pericardial drainage rather than intensifying dialysis should be considered . Since our patient had been on well-controlled dialysis, we considered the possibility of dialysis-associated pericarditis to be low.
Pericardial effusion is observed in 60% of viral pericarditis cases; however, viral pericarditis accompanied by a large effusion resulting in cardiac tamponade is rare . There have been only four reports of cardiac tamponade due to acute pericarditis with coxsackievirus [6, 7, 8, 9]. Although our patient had elevated antibody titers to coxsackievirus as well as elevated levels of several tumor markers in the pericardial effusion, we could not completely rule out pericarditis caused by dialysis or a malignant neoplasm. It was difficult to identify the cause of the pericarditis; thus, we hesitated to perform early AVR at the initial admission.
Based on the above information, the large pericardial effusion that caused the cardiac tamponade in this case was considered to be due to a combination of multiple causes such as severe AS, chronic heart failure, and repeated volume overload due to intermittent hemodialysis, which had caused a medium pericardial effusion. The pericardial effusion increased rapidly after the onset of viral pericarditis, resulting in progression of heart failure and cardiac tamponade.
During the observation, heart failure improved with a single pericardial drainage. The inflammatory response resolved, and recurrence of the pericardial effusion was controlled by anti-inflammatory drugs. On the other hand, the pericardium was tightly adhered to the heart, making the surgery difficult. In such complicated cases, it might be better to consider early surgery; however, it was difficult to decide the optimal surgical timing.
Here, we successfully treated a hemodialysis patient with severe AS complicated by cardiac tamponade and worsened by acute viral pericarditis. We waited for the pericarditis to improve after administering anti-inflammatory agents and performing pericardial drainage and then performed the AVR. The perioperative course of our case was unique and suggestive.
The authors thank Editage (http://www.editage.jp) for the English language editing.
The authors declare that this work was not supported by any grants or funding support.
AH and AY performed the surgery. AH and KA drafted the manuscript. TU and MS provided critical revisions, and all authors approved the final manuscript.
Ethics approval and consent to participate
Consent for publication
Informed consent was obtained from the patient and his family for the publication of this case report and accompanying images.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.